12:32 PM EST - HYTN Innovations Inc : Announces that it has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the Company’s supply agreement with TCann Pty Ltd. HYTN Innovations Inc
shares C.HYTN are trading down $0.03 at $0.28.
